Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesRelapse After Allogeneic Hematopoietic Cell Therapy
Biology of Blood and Marrow Transplantation, 10/29/09
van den Brink MRM et al. – There is a significant need for novel therapies and strategies for relapse following allogeneic HCT, particularly in patients for which DLI is not an option. The National Cancer Institute is sponsoring an international workshop to address issues and research questions relative to the biology, natural history, prevention and treatment of relapse following allogeneic HCT.
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD
Bone Marrow Transplantation, 11/05/09
Management of relapse after allo-SCT for AML and the role of second transplantation
Bone Marrow Transplantation, 10/29/09
Sponsor
Article Search
Sponsor
Sponsor